Skip to main content
Clinical Trials/CTRI/2008/091/000215
CTRI/2008/091/000215
Not yet recruiting
Phase 4

A prospective , randomized controlled trial comparing the efficacy of intravenous cyclophosphamide and alternate day prednisolone versus tacrolimus and alternate day prednisolone for induction of remission in patients with steroid resistant nephrotic syndrome

il0 sites130 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
il
Enrollment
130
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
il

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients with idiopathic steroid resistant nephrotic syndrome
  • (initial or late resistance), 1 to 16 years old , shall be studied . Standard definitions will be used for defining the course of nephrotic syndrome

Exclusion Criteria

  • Patients with impaired renal functions (GFR\<60ml/mt/sqm , serum creatinine \> 1\.2 mg/dl or urea \> 45 mg/dl, confirmed once over a period of 2 weeks).
  • Patients who have received immunosuppressive medications, other than oral prednisolone, in the preceding 6 months.
  • Patients staying more than 200 km from the Institute or those who not willing to come for monthly visits.

Outcomes

Primary Outcomes

Not specified

Similar Trials